Solara Active Pharma Sciences Limited (SOLARA.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 18.77B |
| Enterprise Value | 25.13B |
| P/E Ratio | -1,276.79 |
| PEG Ratio | 4.54 |
| Price/Sales Ratio | 2.41 |
| Price/Book Ratio | 2.64 |
| Enterprise/Revenue | 2.41 |
| Enterprise/EBITDA | 17.81 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -0 |
| Operating Margin | 0.06 |
AD
Management Effectiveness
| Return On Assets | 0 |
| Return On Equity | -0 |
Income Statement
| Revenue | 13.69B |
| Revenue/Share | 308.93 |
| Gross Profit | 3.66B |
| EBITDA | 1.87B |
| Net Income | -74.1M |
| Diluted EPS | -1.68 |
Balance Sheet
| Total Cash | 533.4M |
| Total Cash/Share | 0 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 0 |
| Book Value Per Share | 270.97 |
Price History
| 52-Week Change | 16.05 |
| 52-Week High | 774 |
| 52-Week Low | 422 |
| Moving Average 50 Days | 618.9 |
| Moving Average 200 Days | 543.44 |
Statistics
| Average Volume | 495,769 |
| Shares Outstanding | 48.25M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 217:200 |
| Last Split Date | May 15, 2024 |
AD
